NO20062152L - Fremstilling av 3-azabicyklo [3.1.0.]heksanderivater - Google Patents

Fremstilling av 3-azabicyklo [3.1.0.]heksanderivater

Info

Publication number
NO20062152L
NO20062152L NO20062152A NO20062152A NO20062152L NO 20062152 L NO20062152 L NO 20062152L NO 20062152 A NO20062152 A NO 20062152A NO 20062152 A NO20062152 A NO 20062152A NO 20062152 L NO20062152 L NO 20062152L
Authority
NO
Norway
Prior art keywords
azabicyclo
preparation
hexane derivatives
formula
compound
Prior art date
Application number
NO20062152A
Other languages
English (en)
Inventor
Derek Lawrence Tickner
Jotham Wadsworth Coe
Stanton Furst Mchardy
John Anthony Ragan
Brian Clement Vanderplas
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20062152L publication Critical patent/NO20062152L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Foreliggende oppfinnelse angår en ny og forbedret reduktiv amineringsfremgangsmåte for fremstilling av 3-azabisyklo [3.1.0] hexan derivater med formel I som innbefatter omsetning av en forbindelse med formel II med en forbindelse med formel III
NO20062152A 2003-10-16 2006-05-12 Fremstilling av 3-azabicyklo [3.1.0.]heksanderivater NO20062152L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51188903P 2003-10-16 2003-10-16
PCT/IB2004/003261 WO2005037790A1 (en) 2003-10-16 2004-10-06 Preparation of 3-azabicyclo [3.1.0] hexane derivatives

Publications (1)

Publication Number Publication Date
NO20062152L true NO20062152L (no) 2006-05-12

Family

ID=34465290

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062152A NO20062152L (no) 2003-10-16 2006-05-12 Fremstilling av 3-azabicyklo [3.1.0.]heksanderivater

Country Status (17)

Country Link
US (1) US7129263B2 (no)
EP (1) EP1675829A1 (no)
JP (1) JP2007508367A (no)
KR (1) KR20060096038A (no)
CN (1) CN1867548A (no)
AR (1) AR046592A1 (no)
AU (1) AU2004281229A1 (no)
BR (1) BRPI0415459A (no)
CA (1) CA2540860A1 (no)
CO (1) CO5680416A2 (no)
IL (1) IL174596A0 (no)
MX (1) MXPA06004278A (no)
NO (1) NO20062152L (no)
RU (1) RU2006112576A (no)
TW (1) TW200524866A (no)
WO (1) WO2005037790A1 (no)
ZA (1) ZA200601964B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004052854A2 (en) 2002-12-10 2004-06-24 Wyeth Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
EA009903B1 (ru) * 2003-10-14 2008-04-28 Пфайзер Продактс Инк. Бициклические [3.1.0] производные в качестве ингибиторов переносчиков глицина
WO2008075162A2 (en) * 2006-12-15 2008-06-26 Pfizer Limited Selective mu opioid receptor antagonists for the treatment of female sexual dysfunction
BR112013007566A2 (pt) 2010-09-28 2016-08-02 Panacea Biotec Ltd novos compostos bicíclicos
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
DK3072884T3 (da) * 2013-11-20 2020-03-09 Sanwa Kagaku Kenkyusho Co 3-azabicyclo[3.1.0]hexanderivat og anvendelse deraf til medicinske formål
MX388953B (es) * 2015-05-20 2025-03-20 Ube Industries Cristal de sal de derivado de 3-azabiciclo[3.1.0]hexano novedoso y usos medicionales del mismo.
EP3709810A4 (en) * 2018-03-05 2021-06-30 E. I. du Pont de Nemours and Company PROCESS AND INTERMEDIARIES FOR THE PREPARATION OF CERTAIN MESO-IONIC PESTICIDES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI244481B (en) * 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
JP4155522B2 (ja) * 2001-10-22 2008-09-24 ファイザー・プロダクツ・インク オピオイド受容体アンタゴニストとしての３−アザビシクロ（３．１．０）ヘキサン誘導体

Also Published As

Publication number Publication date
US7129263B2 (en) 2006-10-31
EP1675829A1 (en) 2006-07-05
BRPI0415459A (pt) 2006-12-19
CO5680416A2 (es) 2006-09-29
KR20060096038A (ko) 2006-09-05
US20050113437A1 (en) 2005-05-26
CA2540860A1 (en) 2005-04-28
RU2006112576A (ru) 2006-08-27
WO2005037790A1 (en) 2005-04-28
IL174596A0 (en) 2006-08-20
CN1867548A (zh) 2006-11-22
TW200524866A (en) 2005-08-01
JP2007508367A (ja) 2007-04-05
MXPA06004278A (es) 2006-06-28
AU2004281229A1 (en) 2005-04-28
ZA200601964B (en) 2007-04-25
AR046592A1 (es) 2005-12-14

Similar Documents

Publication Publication Date Title
MY141255A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
NO20070583L (no) Isoindolonforbindelser og anvendelse derav som metabotrofe glutamatreseptorforsterker
ECSP045220A (es) Derivados de n-fenil-2-pirimidin-amina
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
IL217962A0 (en) Process for the preparation of a 2-pyridylethylcarboxamide derivative
YU57603A (sh) Inhibitori fosfodiesteraze 4
TW200500339A (en) Pyrrolidine derivatives, and process for the preparation
MXPA05013474A (es) Derivados de quinolilamida como antagonistas de ccr-5.
BR0315705A (pt) Inibidores de fosfodiesterase-4
AP1816A (en) 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists.
NO20054669L (no) Substituerte kinobenzoxazinanaloger
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
HRP20050803B1 (hr) Novitetna kristalna modifikacija anhidrata boskalida
MY138826A (en) 2,7-substituted indoles
NO20070550L (no) Fremgangsmate for fremstilling av pyrrolotriazinforbindelser
UA66866C2 (uk) Синтез морфолінових похідних
TW200736251A (en) Aryl-isoxazol-4-yl-imidazole derivatives
NO20062599L (no) Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav
WO2005000804A3 (en) Substituted indoles and a process for preparing substituted indoles
CY1108837T1 (el) ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5
MXPA03001272A (es) Procedimiento para la preparacion de dinapsolina.
GB0215392D0 (en) Chemical compounds
BRPI0415459A (pt) preparação de derivados de 3-azabiciclo[3.1.0]hexano
PL1845780T3 (pl) Zastosowanie pochodnych metylofenidatu
NO20063012L (no) Fremgangsmaten for syntesen av perindopril og farmasoytisk akseptable salter derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application